Verity Asset Management Inc. Trims Stock Holdings in Procter & Gamble Company (The) $PG

Verity Asset Management Inc. trimmed its stake in Procter & Gamble Company (The) (NYSE:PG) by 45.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,463 shares of the company’s stock after selling 1,241 shares during the quarter. Verity Asset Management Inc.’s holdings in Procter & Gamble were worth $233,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC boosted its holdings in Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new stake in Procter & Gamble in the first quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. boosted its holdings in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after acquiring an additional 1,674,139 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Down 1.6%

PG stock opened at $147.90 on Tuesday. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43. The business’s 50-day moving average is $153.72 and its two-hundred day moving average is $157.61. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The company has a market cap of $345.61 billion, a price-to-earnings ratio of 21.59, a P/E/G ratio of 3.87 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter in the prior year, the company earned $1.93 earnings per share. Procter & Gamble’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio is currently 61.61%.

Analyst Upgrades and Downgrades

PG has been the topic of several analyst reports. BNP Paribas Exane dropped their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Barclays lowered their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Dbs Bank raised Procter & Gamble to a “moderate buy” rating in a report on Tuesday, October 28th. UBS Group lowered their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Finally, Morgan Stanley set a $175.00 price target on Procter & Gamble in a report on Monday, October 27th. Twelve equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $171.53.

Insider Buying and Selling

In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the sale, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 150,488 shares of company stock valued at $23,529,718 in the last 90 days. Insiders own 0.20% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.